Methenamine Hippurate Tablet
Product Images NDC 70771-1919

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 70771-1919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C3524692 Fabc 438a 9d6e 2cca27172693 01)

Image (C3524692 Fabc 438a 9d6e 2cca27172693 01)
This is a medication information for Methenamine Hippurate tablets, each containing 1 g of the active ingredient. The dosage and administration instructions should be followed as directed. It is recommended to store the tablets at a temperature between 15°C to 30°C. The package is child-resistant and should be kept out of reach of children. The medication is manufactured by Zydus Pharmaceuticals Ltd. in India and is available as a prescription-only drug.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.